Suggest Avoiding Savaysa for A Fib if CrCl is OVER 95 mL/min

Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant...after Pradaxa, Xarelto, and Eliquis.

It's approved for atrial fib and venous thromboembolism (VTE).

But Savaysa has an odd twist when used for A fib. It does NOT work as well as warfarin in patients with NORMAL kidney function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote